A merger between one of the world's largest Pharmaceutical companies and the world's largest Bio-Ag corporation. What could go wrong?
http://money.cnn.com/2016/05/19/investing/monsanto-bayer-merger/index.html?iid=ob_homepage_deskrecommended_poolMonsanto (MON) disclosed late Wednesday that it has received an unsolicited offer from its German rival. Monsanto said its board was reviewing the proposal, but cautioned that a deal was not guaranteed.
While the companies did not disclose the offer's financial terms, Monsanto (MON) is likely to command a price that exceeds its current market value of $42 billion. Any deal would require regulatory approval.
Bayer (BAYRY), which is strongest in Asia and Europe, stands to gain from Monsanto's expertise in agriculture and seeds. The combined company would span pharmaceuticals, consumer health products, agriculture and pesticides.